SCHEMBL13005676

SCHEMBL13005676

CC(C)Cc1cccc(CN(CCN(C)C)Cc2ccccc2F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 1/20 0.45
CAMKK2 Q96RR4 1/20 0.45
TAAR1 Q96RJ0 2/20 0.43
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 4/20 0.39
HTT P42858 1/20 0.39
TSHR P16473 1/20 0.38
AOC3 Q16853 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
GAA P10253 1/20 0.37
POLB P06746 1/20 0.36
CETP P11597 1/20 0.36
BCHE P06276 2/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A3 Q01959 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ACHE P22303 1/20 0.34
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13005575 0.91 CALM1 (0.41) CALM1CAMKK2TAAR1ALDH1A1KDM4E
SCHEMBL13005634 0.91 CALM1 (0.42) CALM1CAMKK2TAAR1ALDH1A1KDM4E
SCHEMBL13005546 0.87 CALM1 (0.47) CALM1CAMKK2ALDH1A1KDM4ETSHR
SCHEMBL13005713 0.86 CALM1 (0.46) CALM1CAMKK2ALDH1A1KDM4ETSHR
SCHEMBL13005440 0.85 CALM1 (0.59) CALM1CAMKK2TAAR1ALDH1A1KDM4E
SCHEMBL13005649 0.85 CALM1 (0.45) CALM1CAMKK2TAAR1ALDH1A1KDM4E
SCHEMBL13005661 0.85 CALM1 (0.45) CALM1CAMKK2TAAR1ALDH1A1KDM4E
SCHEMBL13005566 0.84 CALM1 (0.43) CALM1CAMKK2ALDH1A1KDM4ETSHR
SCHEMBL13005684 0.84 TAAR1 (0.53) CALM1CAMKK2TAAR1ALDH1A1HTT
SCHEMBL13005601 0.84 CYP2D6 (0.46) CALM1CAMKK2ALDH1A1KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed